Dariohealth Corp. current report, 03 July 2014

Business Context and Reporting Period

This Form 8-K is filed by LabStyle Innovations Corp. (not Dariohealth Corp.) with a report date of July 10, 2014, covering an event that occurred on July 3, 2014. The filing addresses Item 3.02 regarding unregistered sales of equity securities resulting from a price adjustment mechanism in a prior private placement.

Key Financial Metrics and Transaction Details

  • Original Offering: Closed February 18, 2014, raising approximately $4.19 million.
  • Original Terms: Issued 2,226,956 shares and warrants for 1,670,216 shares at $1.88 per share.
  • Adjustment Trigger: The "Adjustment Price" (90% of the 10-day lowest VWAP) was calculated at $0.89, significantly below the original offering price of $1.88.
  • Shares Issued (July 3, 2014): 2,484,416 unregistered "Adjustment Shares" issued to buyers.
  • Warrant Adjustments: Exercise price reduced to $0.89 per share; warrant share count increased by 2,746,688 shares.
  • Liquidity and Debt: The filing text does not provide specific data on current revenue, profit, cash flow, margins, or debt levels.

Material Changes and Unusual Items

The primary material change is the significant dilution event triggered by the drop in the company's stock price relative to the private placement price. The issuance of 2,484,416 additional shares and the increase in warrant shares represent a substantial increase in the company's outstanding equity count compared to the initial February 2014 offering.

Outlook, Risks, and Contingencies

  • Future Issuance Risk: The company may be required to issue further Adjustment Shares if the Adjustment Price falls below $0.89 per share during a second Adjustment Period.
  • Timing: The second Adjustment Period commences on the earlier of August 18, 2014, or the date a registration statement for the new shares is declared effective.
  • Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from expectations due to various risks.

Investor Verification Checklist

  • Verify the current total share count and the impact of the 2,484,416 Adjustment Shares on existing shareholder ownership.
  • Confirm the status of the registration statement for the resale of Adjustment Shares and Additional Warrant Shares.
  • Monitor the stock price relative to the $0.89 threshold to assess the risk of further share issuance in the second Adjustment Period.
  • Review the original Securities Purchase Agreement (Exhibit 10.1 to the Feb 12, 2014 8-K) for full terms of the adjustment mechanism.